Now in its 10th year, The Atlantic's Washington Ideas will tackle the most consequential issues of our time with some of the nation's most important leaders from business, politics and culture.
Our mission is to bring journalism to life.
Building on The Atlantic's editorial legacy, we gather top
thinkers and leaders to engage audiences in person and online.
Biosimilars offer the promise of cutting edge treatments, but possibly at lower costs. With society pushing for therapies leading to a cure, can these new class of drugs help answer some of cancer’s most challenging problems?
